Venus Concept to Release Third Quarter of Fiscal Year 2021 Financial Results on November 12, 2021
Venus Concept (NASDAQ: VERO) will announce its Q3 fiscal 2021 financial results on November 12, 2021, prior to market opening. A conference call is scheduled for 8:00 a.m. ET that day, featuring a Q&A session. Participants can join via phone with access code 13723892 or through a live webcast on their investor relations website. Venus Concept specializes in medical aesthetic technologies with a subscription-based sales model across more than 60 countries. The company offers a wide range of aesthetic devices and hair restoration systems, and is supported by prominent healthcare investors.
- Innovative product portfolio in medical aesthetics and hair restoration.
- Subscription-based business model enhancing revenue predictability.
- Strong backing from notable healthcare investors.
- None.
TORONTO, Oct. 04, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced that third quarter of fiscal year 2021 financial results will be released before the market opens on Friday, November 12, 2021.
Management will host a conference call at 8:00 a.m. Eastern Time on November 12, 2021 to discuss the results of the quarter with a question and answer session. Those who would like to participate may dial 877-407-2991 (201-389-0925 for international callers) and provide access code 13723892. A live webcast of the call will also be provided on the investor relations section of the Company's website at ir.venusconcept.com.
For those unable to participate, a replay of the call will be available for two weeks at 877-660-6853 (201-612-7415 for international callers); access code 13723892. The webcast will be archived at ir.venusconcept.com.
About Venus Concept
Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reach in over 60 countries and 19 direct markets. Venus Concept focuses its product sales strategy on a subscription-based business model in North America and in its well-established direct global markets. Venus Concept’s product portfolio consists of aesthetic device platforms, including Venus Versa, Venus Legacy, Venus Velocity, Venus Fiore, Venus Viva, Venus Freeze Plus, Venus Glow, Venus Bliss, Venus Epileve and Venus Viva MD. Venus Concept’s hair restoration systems include NeoGraft®, an automated hair restoration system that facilitates the harvesting of follicles during a FUE process and the ARTAS® and ARTAS iX® Robotic Hair Restoration systems, which harvest follicular units directly from the scalp and create recipient implant sites using proprietary algorithms. Venus Concept has been backed by leading healthcare industry growth equity investors including EW Healthcare Partners (formerly Essex Woodlands), HealthQuest Capital, Longitude Capital Management, and Aperture Venture Partners.
FAQ
When will Venus Concept release its Q3 2021 financial results?
What time is the conference call for Venus Concept's financial results?
How can I participate in Venus Concept's conference call?
What technology does Venus Concept specialize in?
